1. Home
  2. TGT vs EW Comparison

TGT vs EW Comparison

Compare TGT & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Corporation

TGT

Target Corporation

HOLD

Current Price

$98.17

Market Cap

43.7B

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$86.91

Market Cap

45.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGT
EW
Founded
1902
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7B
45.5B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
TGT
EW
Price
$98.17
$86.91
Analyst Decision
Hold
Buy
Analyst Count
27
20
Target Price
$101.04
$95.83
AVG Volume (30 Days)
7.0M
3.0M
Earning Date
11-19-2025
02-10-2026
Dividend Yield
4.58%
N/A
EPS Growth
N/A
N/A
EPS
8.25
2.33
Revenue
$105,242,000,000.00
$5,883,800,000.00
Revenue This Year
N/A
$14.29
Revenue Next Year
$1.80
$9.68
P/E Ratio
$12.06
$37.28
Revenue Growth
N/A
10.60
52 Week Low
$83.44
$65.94
52 Week High
$145.08
$87.89

Technical Indicators

Market Signals
Indicator
TGT
EW
Relative Strength Index (RSI) 59.84 60.64
Support Level $93.77 $85.79
Resistance Level $103.03 $86.98
Average True Range (ATR) 2.71 1.47
MACD 0.13 0.12
Stochastic Oscillator 54.66 90.52

Price Performance

Historical Comparison
TGT
EW

About TGT Target Corporation

Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $106 billion in fiscal 2024 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2024 revenue), beauty and household essentials (30%), food and beverage (23%), hardlines (15%), as well as home furnishings (16%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: